Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2012
09/13/2012WO2012119366A1 Β-lactam compound antibiotic composition
09/13/2012WO2012075414A3 Aptamer bioconjugate drug delivery device
09/13/2012WO2012072570A3 Process for the preparation of a ppi-containing pharmaceutical product
09/13/2012WO2012063005A3 Pharmaceutical composition and dosage form comprising dronedarone, and preparation method thereof
09/13/2012WO2012054425A3 Biodegradable particulate formulations
09/13/2012WO2012026907A3 Cefpodoxime proxetil formulations
09/13/2012WO2011146583A3 Nanoparticulate cinacalcet formulations
09/13/2012WO2011131203A3 A solid pharmaceutical composition for neutralizing stomach acid
09/13/2012US20120232371 Implantable Device Using Ultra-Nanocrystalline Diamond
09/13/2012US20120232328 Drug activation system
09/13/2012US20120232296 Antisolvent solidification process
09/13/2012US20120232157 Methods of using derivatives of (-)-venlafaxine
09/13/2012US20120232136 Substance with sedative effect
09/13/2012US20120231143 Virus-inactivating agent
09/13/2012US20120231093 Method for preparing nano-scale or amorphous particle using solid fat as a solvent
09/13/2012US20120231086 Protein matrix vaccines of improved immunogenicity
09/13/2012US20120231085 Controlled release compositions of gamma-hydroxybutyrate
09/13/2012US20120231084 Galenic form suitable for absorbing, in a specific manner, the undesirable molecules in the digestive tract
09/13/2012US20120231083 Sustained release cannabinoid medicaments
09/13/2012US20120231082 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
09/13/2012US20120231081 Controlled release dosage forms
09/13/2012US20120231080 Controlled release dosage forms
09/13/2012US20120231079 Methods and compositions for controlled delivery of phytochemical agents
09/13/2012US20120231078 Method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (gerd) by specific polysaccharides
09/13/2012US20120231077 Coated Tablets, Their Method of Preparation, and Related Uses
09/13/2012US20120231076 Pharmaceutical compositions comprising rivaroxaban
09/13/2012US20120231075 Abuse-resistant opioid dosage form
09/13/2012US20120231074 Pharmaceutical solid dosage form
09/13/2012US20120231073 Dexlansoprazole compositions
09/13/2012US20120231072 Thermo-responsive hydrogel compositions
09/13/2012US20120231071 Natural product inhibitors of 3dg
09/13/2012US20120231070 Sustained-release liposomal anesthetic compositions
09/13/2012US20120231069 Targeted Nanocarrier Systems for Delivery of Actives Across Biological Membranes
09/13/2012US20120231068 Virucidal properties of various forms of sophorolipids
09/13/2012US20120231067 Vesicle compositions
09/13/2012US20120231066 Multi-drug liposomes to treat tumors
09/13/2012US20120231065 Methods of treating neurological conditions with hematopoeitic growth factors
09/13/2012US20120231064 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
09/13/2012US20120231062 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
09/13/2012US20120231060 Antimicrobial hydrogels, methods of preparation thereof, and articles therefrom
09/13/2012US20120231057 Treatment and prevention of dental pathology in humans and non-human animals
09/13/2012US20120231054 Use of an oleogel containing triterpene for healing wounds
09/13/2012US20120231053 Block Copolymer For Intraperitoneal Administration Containing Anti-Cancer Agent, Micelle Preparation Thereof, And Cancer Therapeutic Agent Comprising The Micelle Preparation As Active Ingredient
09/13/2012US20120231051 Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof
09/13/2012US20120231050 Synthetic Lactone Formulations and Method of Use
09/13/2012US20120231049 Freeze-Thaw Method For Modifying Stent Coating
09/13/2012US20120231048 Medical Devices and Implants from Nb-Ta-W-Zr Alloys
09/13/2012US20120231047 Therapeutic agent delivery for the treatment of asthma via implantable and insertable medical devices
09/13/2012US20120231046 Implant for subcutaneous or intradermal injection
09/13/2012US20120231045 Sustained release compositions of alfuzosin
09/13/2012US20120231044 Vaccine formulation of mannose coated peptide particles
09/13/2012US20120231043 Immobilised biological entities
09/13/2012US20120231042 Pharmaceutical Formulation For Producing Rapidly Disintegrating Tablets
09/13/2012US20120231041 Immunomodulating Nanoparticulate Composition
09/13/2012US20120231040 Cysteine variants of interleukin-11 and methods of use thereof
09/13/2012US20120231039 Chimeric immunomodulatory compounds and methods of using the same-iv
09/13/2012US20120231038 Wound Healing Compositions Comprising Biocompatible Cellulose Hydrogel Membranes and Methods of Use Thereof
09/13/2012US20120231037 Crystalline drug-containing coatings
09/13/2012US20120231036 Cloned biological material medical device and method thereof
09/13/2012US20120230940 Conditioned cell culture medium compositions and methods of use
09/13/2012DE102011106697A1 Wirkstoffhaltiger Schaum sowie Verfahren und Zusammensetzung zu dessen Herstellung Medicated foam and method and composition for the production thereof
09/13/2012CA2829629A1 Protein nanoparticle dispersions
09/13/2012CA2829400A1 Stable formulations for parenteral injection of peptide drugs
09/13/2012CA2829367A1 Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
09/13/2012CA2829354A1 Microneedle devices and methods
09/13/2012CA2829352A1 Microneedle devices and methods
09/13/2012CA2829017A1 Dodecafluoropentane emulsion as a stroke and ischemia therapy
09/13/2012CA2829015A1 Formulation comprising phenylaminopyrimidine derivative as active agent
09/13/2012CA2829006A1 Locally released growth factors to mediate motor recovery after stroke
09/13/2012CA2828640A1 Use of glycopyrrolate for treating tachycardia
09/13/2012CA2828637A1 Semisolid aqueous pharmaceutical composition containing tapentadol
09/13/2012CA2828635A1 Parenteral administration of tapentadol
09/13/2012CA2828631A1 Aqueous pharmaceutical formulation of tapentadol for oral administration
09/13/2012CA2828411A1 Vectors conditionally expressing protein
09/13/2012CA2828395A1 Thiol-containing compounds for the removal of elements from tissues and formulations therefor
09/13/2012CA2826640A1 Pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor
09/13/2012CA2813985A1 Melt-extruded solid dispersions containing an apoptosis-inducing agent
09/12/2012EP2497785A2 Hyaluronic acid derivative and drug containing the same
09/12/2012EP2497484A2 A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
09/12/2012EP2497466A2 Preparation for oral administration
09/12/2012EP2497465A2 Gastroretentive system with alginate body
09/12/2012EP2497464A2 Pharmaceutical composition of imatinibe methanesulphonate and a process for its manufacture
09/12/2012EP2497463A1 Method of protecting biologically active substances against denaturation
09/12/2012EP2497462A1 Stable non-aqueous pharmaceutical compositions
09/12/2012EP2497461A2 Paediatric solutions comprising a beta-blocker
09/12/2012EP2497460A1 Methods of reducing microbial contamination
09/12/2012EP2497459A1 Methods of reducing microbial contamination
09/12/2012EP2497379A2 Stable, durable granules with active agents
09/12/2012EP2497378A2 Stable, durable granules with active agents
09/12/2012EP2497377A2 Stable, durable granules with active agents
09/12/2012EP2497376A2 Stable, durable granules with active agents
09/12/2012EP2497375A2 Stable, durable granules with active agents
09/12/2012EP2497374A2 Stable, durable granules with active agents
09/12/2012EP2497373A2 Stable, durable granules with active agents
09/12/2012EP2497372A2 Stable, durable granules with active agents
09/12/2012EP2497371A2 Stable, durable granules with active agents
09/12/2012EP2497370A2 Stable, durable granules with active agents
09/12/2012EP2496700A1 Nucleic acid-containing lipid particles and related methods
09/12/2012EP2496614A2 Self-assembled particles from zwitterionic polymers and related methods
09/12/2012EP2496587A1 Composition comprising a phosphate, a phosphonate, a phosphite or a phosphoramidate with polyol substructures
1 ... 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 ... 2991